Article citationsMore>>

D. Aune, D. C. Greenwood, D. S. Chan, R. Vieira, A. R. Vieira, D. A. Navarro Rosenblatt, J. E. Cade, V. J. Burley and T. Norat, “Body Mass Index, Abdominal Fatness and Pancreatic Cancer Risk: A Systematic Review and Non-Linear Dose-Response Meta-Analysis Of Prospective Studies,” Annals of Oncology, Vol. 23, No. 4, 2011, pp. 843-852.

has been cited by the following article:

• TITLE: The Role of Hyperinsulenemia as a Risk Factor for Pancreatic Cancer

  AUTHORS: Giuseppe Preziosi, Jude A. Oben, Giuseppe Fusai

  KEYWORDS: Pancreatic Cancer; Obesity; Diabetes; Risk Factors; Hyperinsulenemia

  JOURNAL NAME: Journal of Cancer Therapy, Vol.4 No.10, December 13, 2013

  ABSTRACT: Background: Pancreatic cancer is associated with a very severe prognosis and identification of risk factors is essential. Diabetes and obesity are both established risk factors, and they both cause hyperinsulenemia. With this review we wished to appraise the evidence of a role of high insulin levels in causing pancreatic cancer. Methods: We searched PubMed, Embase, Cochrane Library and Medline, and all evidence on potential pathophysiology of hyperinsulenemia and pancreatic cancer was included. Metaand pooled-analysis on epidemiological evidence are reported, and individual studies were as appropriate for specific topics (role of therapies, central adiposity and role of physical exercise). Conclusion: Hyperinsulenemia, and possibly hyperestrogenism secondary to a metabolic syndrome, are important elements in the pathogenesis of pancreatic cancer. Modification of certain life-style factors (exercise and weight loss) appears to modify the risk of pancreatic malignancy.